Probiotics Market Revolution Needs Supplement Industry As Torchbearer
This article was originally published in The Tan Sheet
Executive Summary
Supplement firms should take the reins of probiotic research and promotion before the pharmaceutical industry controls the message, suggests Peter Leighton, Abunda Functional Foods CEO. Interest in manipulating the microbiome for therapeutic effect has garnered interest from pharma giants including J&J.
You may also be interested in...
DuPont Venture With Microbiome Startup Analyzing Probiotic Impact On Gut Health
DuPont Microbiome Venture signs agreement with BioMe Oxford to develop BioCapture ingestible capsule that samples gut health to assess the impact of probiotics and other nutrients on microbiome. Product should help shape future of precision medicine, firms say.
Probiotic Beer Headed For Increasingly Specialized 'Good Bacteria' Market
National University of Singapore researchers are looking for an industry partner to market their "gut-friendly" probiotic sour beer, signaling rising awareness in the research community regarding the opportunity for probiotics. Consultant Laura Mahecha discussed the growing probiotics market in a June 28 webinar hosted by Kline & Company.
Probiotic Claims Hit Regulatory Wall, But Media Gives An Advertising Lift
Burgeoning research reaches consumers with information that probiotics help with conditions from irritable bowel syndrome to colds, eczema, constipation and diarrhea. “People absorb that information and then they show up and they buy bugs in a bottle,” says health care marketing consultant Kim Wagner.